Literature DB >> 3036994

Single germline VH and V kappa genes encode predominating antibody variable regions elicited in strain A mice by immunization with p-azophenylarsonate.

L J Wysocki, T Gridley, S Huang, A G Grandea, M L Gefter.   

Abstract

We have cloned and sequenced the predominant germline V kappa gene segment expressed by B cells of strain A origin that synthesize antibodies with specificity for Ars. In hybridomas synthesizing anti-Ars antibodies, this V kappa gene segment (V kappa IdCR) has been found exclusively associated with the J kappa 1 gene segment without exhibiting junctional sequence variation. Sequence comparisons of the germline V kappa IdCR gene with expressed derivatives reveals that the latter frequently contain somatically introduced amino acid replacements. Taken together with results of previous structural analyses, these results show that the predominant population of IdCR+ V regions elicited in the secondary immune response is encoded by one or two combinations of V gene segments, has little junctional diversity, and is extensively diversified by somatic mutation in both heavy and light chains.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3036994      PMCID: PMC2188650          DOI: 10.1084/jem.166.1.1

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  40 in total

1.  Sequences at the somatic recombination sites of immunoglobulin light-chain genes.

Authors:  H Sakano; K Hüppi; G Heinrich; S Tonegawa
Journal:  Nature       Date:  1979-07-26       Impact factor: 49.962

2.  Sequences of mouse immunoglobulin light chain genes before and after somatic changes.

Authors:  O Bernard; N Hozumi; S Tonegawa
Journal:  Cell       Date:  1978-12       Impact factor: 41.582

3.  Multiplicity of germline genes specifying a group of related mouse kappa chains with implications for the generation of immunoglobulin diversity.

Authors:  O Valbuena; K B Marcu; M Weigert; R P Perry
Journal:  Nature       Date:  1978 Dec 21-28       Impact factor: 49.962

4.  A new method for sequencing DNA.

Authors:  A M Maxam; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

5.  The joining of V and J gene segments creates antibody diversity.

Authors:  M Weigert; R Perry; D Kelley; T Hunkapiller; J Schilling; L Hood
Journal:  Nature       Date:  1980-01-31       Impact factor: 49.962

6.  Hybridoma proteins expressing the predominant idiotype of the antiazophenylarsonate response of A/J mice.

Authors:  A Marshak-Rothstein; M Siekevitz; M N Margolies; M Mudgett-Hunter; M L Gefter
Journal:  Proc Natl Acad Sci U S A       Date:  1980-02       Impact factor: 11.205

7.  Complete amino acid sequences of the heavy and light chain variable regions from two A/J mouse antigen nonbinding monoclonal antibodies bearing the predominant p-azophenyl arsonate idiotype.

Authors:  J A Smith; M N Margolies
Journal:  Biochemistry       Date:  1987-01-27       Impact factor: 3.162

8.  Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion.

Authors:  G Köhler; C Milstein
Journal:  Eur J Immunol       Date:  1976-07       Impact factor: 5.532

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Quantitative investigations of idiotypic antibodies. VI. Idiotypic specificity as a potential genetic marker for the variable regions of mouse immunoglobulin polypeptide chains.

Authors:  M G Kuettner; A L Wang; A Nisonoff
Journal:  J Exp Med       Date:  1972-03-01       Impact factor: 14.307

View more
  22 in total

1.  B-cell proliferation initiated by Ia cross-linking and sustained by interleukins leads to class switching but not somatic mutation in vitro.

Authors:  L J Wysocki; G Creadon; K R Lehmann; J C Cambier
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

2.  Sequencing heavy- and light-chain variable genes of single B-hybridoma cells by total enzymatic amplification.

Authors:  A H Liu; G Creadon; L J Wysocki
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

3.  Silent development of memory progenitor B cells.

Authors:  Katja Aviszus; Xianghua Zhang; Lawrence J Wysocki
Journal:  J Immunol       Date:  2007-10-15       Impact factor: 5.422

4.  Monitoring the acute phase response: comparison of tumour necrosis factor (cachectin) and C-reactive protein responses in inflammatory and infectious diseases.

Authors:  C P Maury
Journal:  J Clin Pathol       Date:  1989-10       Impact factor: 3.411

5.  Structural correlates of high antibody affinity: three engineered amino acid substitutions can increase the affinity of an anti-p-azophenylarsonate antibody 200-fold.

Authors:  J Sharon
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

6.  Lack of connectivity between the induced and autoimmune repertoires of lpr/lpr mice.

Authors:  D L Very; D J Panka; D Weissman; L Wysocki; T Manser; A Marshak-Rothstein
Journal:  Immunology       Date:  1993-12       Impact factor: 7.397

7.  Crystal structure of the antigen-binding fragment of the murine anti-arsonate monoclonal antibody 36-71 at 2.9-A resolution.

Authors:  D R Rose; R K Strong; M N Margolies; M L Gefter; G A Petsko
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

8.  Immunoglobulin constant kappa gene alleles in twelve strains of mice.

Authors:  M L Solin; M Kaartinen
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

9.  Nucleotide sequence analysis of CDR3 elements of a panel of anti-peptide monoclonal antibodies recognizing parathyroid hormone-related protein.

Authors:  R Rapley; P S Flora; D J Walsh; M R Walker
Journal:  Immunology       Date:  1993-03       Impact factor: 7.397

10.  Isotype switching by a microinjected mu immunoglobulin heavy chain gene in transgenic mice.

Authors:  J Durdik; R M Gerstein; S Rath; P F Robbins; A Nisonoff; E Selsing
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.